Delivery. Spontaneous vertex delivery
Conditions
Interventions
Intervention 1: Intervention group (promethazine ): at the beginning of the active phase, women in the promethazine group, in addition to receiving routine care, will be injected intramuscularly with
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Age between 18 and 35 years Full-term pregnancy Primiparous Single and live fetus with cephalic presentation Estimated fetal weight between 2500 and 4000 grams Low-risk pregnancy No use of narcotic drugs and painkillers during In the past 48 hours The absence of chronic and systemic diseases such as diabetes, hypertension, heart disease, epilepsy The beginning of the active phase (3-4 cm cervical dilatation) No rupture of membrane
Exclusion criteria
Exclusion criteria: Withdrawal of participants during the study The occurrence of any obstetric emergencies Contraindications of normal delivery such as: fetal distress, placental abruption, severe vaginal bleeding, umbilical cord prolapse, etc. The occurrence of emergency cesarean section before the completion of the study Non-cooperation of participants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Labor pain severity. Timepoint: Before the intervention, two and four hours after the intervention. Method of measurement: Pain visual analog scale.;Delivery progression. Timepoint: Before the intervention, two and four hours after the intervention. Method of measurement: Partograph form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactForuzan Sharifipour
Kermanshah University of Medical Sciences
Outcome results
None listed